arrow
Y

Yafeng Xue

AstraZeneca
H指数:33
被引数:3,260

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Design of Bicyclic Peptide Tandems Mimicking the Homodimeric GDF15 Protein to Inhibit GDF15–GFRaL–RET Complex Cell Signaling

双环肽串联的设计:模拟同源二聚体GDF15蛋白以抑制GDF15–GFRaL–RET复合物细胞信号传导

2025-10-090
PRE
Identification and optimisation of a pyrimidopyridone series of IRAK4 inhibitors

嘧啶并吡啶酮系列IRAK4抑制剂的鉴定和优化

2022-06-012
PRE
AZD0284, a Potent, Selective, and Orally Bioavailable Inverse Agonist of Retinoic Acid Receptor-Related Orphan Receptor C2
2021-08-3111
PRE
Improving metabolic stability and removing aldehyde oxidase liability in a 5-azaquinazoline series of IRAK4 inhibitors
2020-12-014
PREAI
Discovery of Potent and Orally Bioavailable Inverse Agonists of the Retinoic Acid Receptor-Related Orphan Receptor C2
2019-05-2921
OAAI
Potent and Orally Bioavailable Inverse Agonists of RORγt Resulting from Structure-Based Design
2018-08-1031
PREAI
Structure-Based Drug Design of Mineralocorticoid Receptor Antagonists to Explore Oxosteroid Receptor Selectivity

基于结构的盐皮质激素受体拮抗剂药物设计探索氧类固醇受体选择性

2016-12-1511
OAAI
Discovery of Checkpoint Kinase Inhibitor (S)-5-(3-Fluorophenyl)-N-(piperidin-3-yl)-3-ureidothiophene-2-carboxamide (AZD7762) by Structure-Based Design and Optimization of Thiophenecarboxamide Ureas
2012-06-0468
PREAI